2026 News Feed

JCI Insight

Researchers Find Peroxisomes Help Protect Insulin and Maintain Beta Cell Health

Researchers at LSU’s Pennington Biomedical Research Center have identified a previously underappreciated role for tiny structures inside cells called peroxisomes in protecting insulin and maintaining the health and maturity of insulin-producing pancreatic beta cells.

Learn More
Metamor

Study Finds Extreme Obesity Common Among Bariatric Surgery Patients, Should Not Preclude Treatment

Patients with extreme obesity are more common among those undergoing metabolic and bariatric surgery than previously recognized, and although they face a greater burden of certain health conditions and surgical complications, their overall surgical risk remains relatively low, according to a new study led by researchers at LSU’s Pennington Biomedical Research Center.

Learn More
Be the Reason

2026 Childhood Obesity Conference: “Be the Reason Kids Greaux Healthy” to be held Sept. 24

LSU’s Pennington Biomedical Research Center will host its 2026 Childhood Obesity Conference, “Be the Reason Kids Greaux Healthy,” on Sept. 24 at the C.B. Pennington, Jr. Conference Center. The conference, presented by the Greaux Healthy initiative, will bring together health care professionals, researchers, educators and community leaders to explore strategies for preventing and treating childhood obesity. Registration is now available online.

Learn More
The Answer

Pennington Biomedical Research Foundation Announces 2027 The Answer Gala will be held March 20; Sponsorship Opportunities Now Available

The Pennington Biomedical Research Foundation has announced its signature fundraising event, The Answer, will return on Saturday, March 20, 2027, at L'Auberge Casino & Hotel. One of Baton Rouge's premier charitable events, the annual gala brings together community leaders, philanthropists and supporters for an unforgettable evening dedicated to advancing life-changing work at Pennington Biomedical Research Center.

Learn More
Heymsfield GLP-1

Researchers Examine Unanticipated Benefits of GLP-1 Medications

GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU’s Pennington Biomedical Research Center and Dr. Adam Gilden of the University of Colorado examines what scientists are learning as these medications reach millions of people.

Learn More
Teen Driver

Pennington Biomedical and Minnesota HealthSolutions Awarded NIH Grant to Develop Digital Driving Safety Platform for Teens with ADHD

Dr. Jeffrey Keller, Hibernia National Bank/Edward G. Schleider Endowed Chair at LSU's Pennington Biomedical Research Center, and Sara Seifert, president of Minnesota HealthSolutions, have received a new National Institutes of Health Small Business Innovation Research (SBIR) award to develop an innovative digital health platform that will help parents support teenagers with attention-deficit/hyperactivity disorder (ADHD) as they learn to drive. Teen drivers with ADHD represent one of the highest risk groups for motor vehicle crashes.

Learn More
Lancet Commission on Clinical Obesity

New Approach to Obesity Classification Could Better Guide Treatment Decisions

A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by focusing on the effects of excess adiposity on organs and tissues rather than relying primarily on whether a person meets a set of metabolic risk thresholds.

Learn More
Louisiana Health Fellow

Dr. Jennifer Rood Selected for Inaugural Leadership Louisiana Health Fellows Class

Dr. Jennifer Rood, Interim Senior Vice Chancellor and Executive Director of LSU’s Pennington Biomedical Research Center, has been selected as a member of the inaugural Leadership Louisiana Health Fellows class.

Learn More
Men's Health Summit

Pennington Biomedical Men's Health Summit 2026 to be Held Aug. 22

Presented by FMOL Health | Our Lady of the Lake and hosted by Pennington Biomedical Research Center and the Pennington Biomedical Research Foundation, the free summit is available to all over the age of 18.

Learn More
LiBBY

Topline Results from LiBBY Trial Show THC/CBD Combination Significantly Reduces Agitation for People with Dementia at End of Life

A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest topline results from the Phase 2 LiBBY (Life’s End Benefits of cannaBidiol and tetrahYdrocannabinol) clinical trial. The findings were reported for the first time at the Alzheimer’s Association International Conference 2026 in London and online.

Learn More